company background image
SKIN

Beauty Health NasdaqCM:SKIN Stock Report

Last Price

US$10.89

Market Cap

US$1.6b

7D

6.9%

1Y

-55.2%

Updated

07 Dec, 2022

Data

Company Financials +
SKIN fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance3/6
Financial Health3/6
Dividends0/6

SKIN Stock Overview

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

The Beauty Health Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beauty Health
Historical stock prices
Current Share PriceUS$10.89
52 Week HighUS$25.85
52 Week LowUS$8.27
Beta0.97
1 Month Change-1.63%
3 Month Change-10.74%
1 Year Change-55.18%
3 Year Changen/a
5 Year Changen/a
Change since IPO0.46%

Recent News & Updates

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Recent updates

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Apr 22
Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

The Beauty Health Company's (NASDAQ:SKIN) Intrinsic Value Is Potentially 59% Above Its Share Price

Oct 11
The Beauty Health Company's (NASDAQ:SKIN) Intrinsic Value Is Potentially 59% Above Its Share Price

Shareholder Returns

SKINUS Personal ProductsUS Market
7D6.9%8.6%-0.4%
1Y-55.2%-35.6%-20.6%

Return vs Industry: SKIN underperformed the US Personal Products industry which returned -34.5% over the past year.

Return vs Market: SKIN underperformed the US Market which returned -17.6% over the past year.

Price Volatility

Is SKIN's price volatile compared to industry and market?
SKIN volatility
SKIN Average Weekly Movement11.7%
Personal Products Industry Average Movement10.7%
Market Average Movement7.4%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.3%

Stable Share Price: SKIN is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: SKIN's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1997704Andrew Stanleickhttps://www.beautyhealth.com

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer’s preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health.

The Beauty Health Company Fundamentals Summary

How do Beauty Health's earnings and revenue compare to its market cap?
SKIN fundamental statistics
Market CapUS$1.56b
Earnings (TTM)US$23.26m
Revenue (TTM)US$345.63m

67.1x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SKIN income statement (TTM)
RevenueUS$345.63m
Cost of RevenueUS$103.71m
Gross ProfitUS$241.93m
Other ExpensesUS$218.67m
EarningsUS$23.26m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.16
Gross Margin69.99%
Net Profit Margin6.73%
Debt/Equity Ratio285.1%

How did SKIN perform over the long term?

See historical performance and comparison